Published :
Tables : 110
Figures : 40
Category : Healthcare
No. of Pages : 231
Report Code : HC-1175
Digital PCR (dPCR) and Real-time PCR (qPCR) market is expected to value over USD 7.1 billion with a CAGR of over 8% during the forecast period 2020 to 2027. The new advances and current research on dPCR and qPCR techniques are spurring market growth. Both the techniques deal with sequencing of DNA or a gene to make millions of copies. Due to its wide applications in genetics, pharmaceuticals, clinical research, forensic science and so on; the qPCR and dPCR market is growing at a rapid rate across the globe. Rising risk of genetic disorders, infectious diseases along with awareness, diagnostic centres and hospital requirements serve as one of the major factors responsible for the rapid growth of digital PCR (dPCR) and real-time PCR (qPCR) market. Furthermore, the ease of using the dPCR and qPCR techniques by reducing the number of procedures increases the preference of end users towards accepting these techniques. The market is segmented into product and service, applications, end users and region. In terms of application, diagnostics, research, biopharmaceuticals,etc. are drivers for market growth. The instruments segment is anticipated to be the dominating factor that contributes to rapid market scale-up. Clinical and research applications are expected to be drivers for the demand of dPCR and qPCR market. This is because of the inclination of government and non-government bodies towards research in this sector and the funds provided by them and the range of clinical applications like blood screening, oncology testing and diagnosis of other diseases. North America, Europe and the Asia Pacific regions are anticipated to hold major market shares in dPCR and qPCR market. The increased disease conditions in these regions due to lifestyle habits and increasing population are drivers for market growth in these regions. Furthermore, the demand of dPCR and qPCR research and pharmaceutical advances is more in these regions which support the growth of the market. Competitive Landscape: The major players in the market are Abbott Laboratories, Agilent Technologies, Inc, Analytik Gena AG, Becton Dickinson and Company, Biomérieux S.A., Bio-Rad Laboratories, Inc., Danaher Corporation, Hoffman-La Roche Ltd., Fluidigm Corporation, Thermo Fisher Scientific, Inc. Abbott Laboratories is estimated to have a large share amongst other competitors. It has a range of advanced dPCR and qPCR products for diagnosis of infectious diseases, oncology testing, genetic testing and so on. Digital PCR (dPCR) and Real-time PCR (qPCR) Market Segmentation: By Product and Service qPCR products and services qPCR reagents and consumables qPCR instruments qPCR software and services dPCR products and services dPCR reagents and consumables dPCR instruments qPCR software and services By Application qPCR applications and dPCR applications Forensic applications Research applications Clinical applications Infectious disease testing Oncology testing Blood screening Transplant diagnostics Other applications By End User dPCR and qPCR end users Hospitals and diagnostic centres Research Laboratories and Academic Institutes Pharmaceutical and Biotechnology companies Clinical research organizations Forensic laboratories By Region North America Europe Asia pacific Latin America Middle East and Africa FutureWise Key Takeaways: Research and development in PCR technology and pharmaceuticals Focus on new advances in PCR diagnostic instruments Commercialization of qPCR and dPCR methods Objectives of the Study: To provide with an exhaustive analysis on the digital PCR (dPCR) and Real-time PCR (qPCR) market by product and service, by application, by end user and by region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)— North America, Asia Pacific, Europe, Latin America and Middle East & Africa To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Profiling of companies to evaluate their market shares, strategies, financials and core competencies Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization services offered are free of charge with purchase of any license of the report. You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
The new advances and current research on dPCR and qPCR techniques are spurring market growth. Both the techniques deal with sequencing of DNA or a gene to make millions of copies. Due to its wide applications in genetics, pharmaceuticals, clinical research, forensic science and so on; the qPCR and dPCR market is growing at a rapid rate across the globe.
Rising risk of genetic disorders, infectious diseases along with awareness, diagnostic centres and hospital requirements serve as one of the major factors responsible for the rapid growth of digital PCR (dPCR) and real-time PCR (qPCR) market. Furthermore, the ease of using the dPCR and qPCR techniques by reducing the number of procedures increases the preference of end users towards accepting these techniques.
The market is segmented into product and service, applications, end users and region. In terms of application, diagnostics, research, biopharmaceuticals,etc. are drivers for market growth. The instruments segment is anticipated to be the dominating factor that contributes to rapid market scale-up.
Clinical and research applications are expected to be drivers for the demand of dPCR and qPCR market. This is because of the inclination of government and non-government bodies towards research in this sector and the funds provided by them and the range of clinical applications like blood screening, oncology testing and diagnosis of other diseases.
North America, Europe and the Asia Pacific regions are anticipated to hold major market shares in dPCR and qPCR market. The increased disease conditions in these regions due to lifestyle habits and increasing population are drivers for market growth in these regions. Furthermore, the demand of dPCR and qPCR research and pharmaceutical advances is more in these regions which support the growth of the market.
Competitive Landscape:
The major players in the market are Abbott Laboratories, Agilent Technologies, Inc, Analytik Gena AG, Becton Dickinson and Company, Biomérieux S.A., Bio-Rad Laboratories, Inc., Danaher Corporation, Hoffman-La Roche Ltd., Fluidigm Corporation, Thermo Fisher Scientific, Inc.
Abbott Laboratories is estimated to have a large share amongst other competitors. It has a range of advanced dPCR and qPCR products for diagnosis of infectious diseases, oncology testing, genetic testing and so on.
Digital PCR (dPCR) and Real-time PCR (qPCR) Market Segmentation:
By Product and Service
By Application
By End User
By Region
FutureWise Key Takeaways:
Objectives of the Study:
Flexible Delivery Model:
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Digital PCR (dPCR) and Real-time PCR (qPCR) Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market, By Product and Service Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. qPCR products and services 7.1.1. qPCR reagents and consumables 7.1.2. qPCR instruments 7.1.3. qPCR software and services 7.2. dPCR products and services 7.2.1. dPCR reagents and consumables 7.2.2. dPCR instruments 7.2.3. dPCR software and services 8. Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. qPCR applications and dPCR applications 8.1.1. Forensic applications 8.1.2. Research applications 8.1.3. Clinical applications 8.1.3.1. Infectious disease testing 8.1.3.2. Oncology testing 8.1.3.3. Blood screening 8.1.3.4. Transplant diagnostics 8.1.3.5. Other applications 9. Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million) 9.1. dPCR and qPCR end users 9.1.1. Hospitals and diagnostic centres 9.1.2. Research Laboratories and Academic Institutes 9.1.3. Pharmaceutical and Biotechnology companies 9.1.4. Clinical research organizations 9.1.5. Forensic laboratories 10. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2020-2027 11. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Regional Market Trends 11.3. Historical Market Size (USD Million) Analysis By Country, 2015-2019 11.3.1. Brazil 11.3.2. Venezuela 11.3.3. Argentina 11.3.4. Rest of Latin America 11.4. Market Size (USD Million) Forecast for Latin America 2020-2027 12. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Switzerland 12.2.9. Rest of Western Europe 12.3. Market Size (USD Million) Forecast for Europe 2020-2027 13. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.2.1. Japan 13.2.2. China 13.2.3. Singapore 13.2.4. India 13.2.5. Australia and New Zealand 13.2.6. ASEAN 13.2.7. South Korea 13.2.8. Taiwan 13.2.9. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 14. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 14.2.1. Saudi Arabia 14.2.2. UAE 14.2.3. South Africa 14.2.4. Egypt 14.3. Market Size (USD Million) Forecast for MEA 2020-2027 15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts) 15.1. Abbott Laboratories 15.1.1. Company Overview 15.1.2. Product Portfolio 15.1.3. SWOT Analysis 15.1.4. Financial Overview 15.1.5. Strategic Overview 15.2. Agilent Technologies, Inc 15.2.1. Company Overview 15.2.2. Product Portfolio 15.2.3. SWOT Analysis 15.2.4. Financial Overview 15.2.5. Strategic Overview 15.3. Analytik Gena AG 15.3.1. Company Overview 15.3.2. Product Portfolio 15.3.3. SWOT Analysis 15.3.4. Financial Overview 15.3.5. Strategic Overview 15.4. Becton Dickinson and Company 15.4.1. Company Overview 15.4.2. Product Portfolio 15.4.3. SWOT Analysis 15.4.4. Financial Overview 15.4.5. Strategic Overview 15.5 Biomérieux S.A 15.5.1. Company Overview 15.5.2. Product Portfolio 15.5.3. SWOT Analysis 15.5.4. Financial Overview 15.5.5. Strategic Overview 15.6 Bio-Rad Laboratories, Inc. 15.6.1. Company Overview 15.6.2. Product Portfolio 15.6.3. SWOT Analysis 15.6.4. Financial Overview 15.6.5. Strategic Overview 15.7. Danaher Corporation 15.7.1. Company Overview 15.7.2. Product Portfolio 15.7.3. SWOT Analysis 15.7.4. Financial Overview 15.7.5. Strategic Overview 15.8. Hoffman-La Roche Ltd. 15.8.1. Company Overview 15.8.2. Product Portfolio 15.8.3. SWOT Analysis 15.8.4. Financial Overview 15.8.5. Strategic Overview 15.9. Fluidigm Corporation 15.9.1. Company Overview 15.9.2. Product Portfolio 15.9.3. SWOT Analysis 15.9.4. Financial Overview 15.9.5. Strategic Overview 15.10. Thermo Fisher Scientific, Inc. 15.10.1. Company Overview 15.10.2. Product Portfolio 15.10.3. SWOT Analysis 15.10.4. Financial Overview 15.10.5. Strategic Overview 16. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics